Upstate Active Clinical Trials

Study Title:

Intensified Methotrexate, Nelarabine (Compound 506U78; IND# 52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia

What is the purpose of the study?

Randomized treatment study to look at different combination chemotherapy regimens & their side effects and comparing how well they work in treating young patients with newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:


Study Phase:


Patient Age Group:


Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:


For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232

Return to Previous Page || Search Again